Perioperative cardiac events in endovascular repair of complex aortic aneurysms and association with preoperative studies  by Bub, Guilherme L. et al.
From the Society for Vascular Surgery
Perioperative cardiac events in endovascular repair
of complex aortic aneurysms and association with
preoperative studies
Guilherme L. Bub, MD,a Roy K. Greenberg, MD,a,b Tara M. Mastracci, MD,a
Matthew J. Eagleton, MD,a Giuseppe Panuccio, MD,a Adrian V. Hernandez, MD, PhD,c and
Manuel D. Cerqueira, MD,d Cleveland, Ohio
Background: Endovascular repair of complex aortic aneurysms (CAAs) can be performed in high-risk individuals, yet is
still associated with significant morbidity, including spinal cord ischemia, cardiac complications, and death. This analysis
was undertaken to better define the cardiac risk for CAA.
Methods: A prospective database of patients undergoing thoracoabdominal or juxtarenal aortic aneurysm repair with
branched and fenestrated endografts was used to retrospectively determine the number of cardiac events, defined as
myocardial infarction (MI), atrial fibrillation (AF), and ventricular arrhythmia (VA), that occurred<30 days of surgery.
Postoperative serial troponin measurements were performed in 266 patients. Any additional available cardiac informa-
tion, including preoperative echocardiography, physiologic stress tests, and history of cardiac disease, was obtained from
medical records. The efficacy of preoperative stress testing and the association of various echo parameters were evaluated
in the context of cardiac outcomes using univariable and multivariable logistic regression models.
Results: Between August 2001 and December 2007, 395 patients underwent endovascular repair of a thoracoabdominal
or juxtarenal aortic aneurysm. The incidence of AF, VA, and 30-day cardiac-related death was 9%, 3%, and 2%,
respectively. Overall 30-day mortality was 6%. Univariable analysis showed the presence of mitral annulus calcification was
associated with MI (odds ratio [OR], 3.5; 95% confidence interval [CI], 0.9-13.8; P .07). Left atrium cavity area, ejection
fraction, left ventricle mass, and left ventricular mass index were univariably associated with the presence of VA.Multivariable
analysis showed only the left atrium cavity area was independently associated with VA (OR, 1.2; 95% CI, 1.0-1.5; P  .07).
Stress test was done in 179 patients.Negative stress test results occurred in 152 (85%), ofwhom9 (6%) sustained anMIduring
the 30-day perioperative course. MI occurred in 2 of the 27 patients (7%) who had a positive stress test result.
Conclusions: Endovascular repair of CAA can be performed in high-risk individuals but is associated with significant
cardiac risk. It remains difficult to risk stratify patients using preoperative stress testing. Echo evaluation may help to
identify patients who may be more likely to develop ventricular arrhythmias in the postoperative period and thus warrant
closer monitoring. Postoperative troponin monitoring of all patients undergoing repair of CAA is warranted given the
overall risk of MI. (J Vasc Surg 2011;53:21-7.)Surgical treatment of thoracoabdominal aneurysm
(TAA) was first reported in 19551 and remains a challenge
for clinicians. Conventional surgery for TAA is associated
with a 30-day mortality rate of 5% to 23%.2-10 Endovascu-
lar repair is a minimally invasive technique that may
decrease the risk of periprocedural complications, thus
expanding the patient population considered eligible for
treatment and decreasing complications in conventional-
risk patients.12,13 Development of fenestrated and
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repair of thoracoabdominal and juxtarenal aneurysms.
We have previously reported acceptable mortality and
spinal cord ischemia rates compared with a healthier
cohort undergoing conventional, open repair.14 Patient
age, renal insufficiency, aneurysm extent, cardiac func-
tion, and emergency presentation have been identified
previously as risk factors for death after conventional
aortic surgery.15-19 The prevalence of underlying coro-
nary artery disease (CAD) in patients with aortic aneu-
rysms has been reported as 30% to 70%, and it is also
associated with increased mortality and cardiac compli-
cations during the postoperative period.11,20-23
Despite consensus-based guidelines,27 optimal man-
agement of CAD during the preoperative workup for major
vascular surgery remains controversial.16,18,24-26 The aim
of this study was to describe the incidence of cardiac events
in patients undergoing endovascular repair of complex
abdominal and TAAs and to evaluate the association be-
tween preoperative patient information derived from 2-
dimensional transthoracic echocardiograms, cardiac stress
tests, and intervention, and perioperative cardiac morbidity
and mortality.
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A retrospective review was performed of a prospectively
collected database of patients undergoing TAA or juxtare-
nal aortic aneurysm repair using branched and fenestrated
endografts under a physician-sponsored investigational de-
vice exemption protocol, between August 2001 and De-
cember 2007. All patients enrolled were considered high-
risk for conventional open surgery and signed a consent
approved by the Institutional Review Board.
We evaluated baseline clinical characteristics, the num-
ber of cardiac events 30 days of surgery, and 30-day
cardiac-related mortality. Medical records were retrospec-
tively reviewed to determine the number of patients with
troponin T levels 0.1 ng/mL during the 30-day period
after surgery and the results of bidimensional transthoracic
echocardiogram, stress tests, cardiac catheterizations, and
any other coronary intervention. The decision for the pa-
tient to undergo cardiac testing or risk stratification was at
the discretion of the treating surgeon.
A cardiac event was defined as myocardial infarction
(MI), ventricular arrhythmia, and atrial fibrillation (new
onset or that required changes in a previous prescription).
MI was defined in accordance with the latest consensus
document, indicated by troponin T 0.1 ng/mL associ-
ated with symptoms of angina, electrocardiogram changes
of ischemia, or wall motility changes verified through echo-
cardiogram.28 Ventricular arrhythmia was documented
when sustained or nonsustained ventricular tachycardia or
ventricular fibrillation was verified by telemetry or electro-
cardiogram, if treatment was provided. The echocardio-
gram parameters were used to analyze wall motion abnor-
mality (WMA), presence of mitral annular calcification
(MAC), left atrium size (LAS) and cavity area (LACA), and
left ventricular mass (LVM) and mass index (LVMI). LVM
was calculated as described by Deveraux et al29,30 and
LVMI as the result of LVM divided by body surface area.
Continuous variables were described as mean with the
standard deviation (SD) and categoric variables as number
and percentage. Univariable and multivariable logistic re-
gression models were used to evaluate the associations
between preoperative echocardiographic parameters and
myocardial events. Echocardiographic parameters were de-
termined a priori and included wall motion abnormality,
MAC, LACA, LA size, EF, LVM, LVMI, and stage of
diastolic dysfunction. Associations from the logistic models
are given as odds ratios (ORs) with 95% confidence inter-
vals (95% CIs) and P values. Variables with a P  .2 in the
univariable analysis were chosen for the multivariable anal-
ysis. In the multivariable analysis, variables with a P  .05
were regarded as significant. All analyses were done using
S-Plus 7.0 software (Insightful Corp, Seattle, Wash).
RESULTS
A total of 395 patients underwent endovascular repair
of complex aortic aneurysms using custom-made fenes-
trated and branched devices. Retrospective review identi-
fied postoperative serial troponin T measurements wereperformed in 266 patients (Fig 1), and all remaining pa-
tients were excluded from analysis. Patient baseline charac-
teristics are reported in Table I. The mean age was 74 years,
with a high prevalence of reported CAD (78%) and chronic
obstructive pulmonary disease (35%), of which 46% (42 of
92) were dependent on home oxygen supplementation. All
patients underwent some form of preoperative cardiac eval-
uation (Fig 2). A stress test was performed and reached
adequate myocardial stressing in 179 patients, and 160
patients underwent preoperative echocardiography. Car-
diac catheterization was done in 49, and 18 were cleared by
the cardiologist without any further cardiac tests. In 20
patients, we were not able to retrieve data from the preop-
erative cardiac evaluation.
Percutaneous coronary intervention (PCI) was per-
formed in 19 patients during the preoperative workup (8
patients after a positive stress test, the remaining as a result
of symptoms). Continued medical treatment was recom-
mended in those patients without critical coronary stenosis
or with unsuitable anatomy for PCI. Coronary artery by-
pass grafting (CABG) was performed in 12 patients before
the endovascular procedure as a result of the cardiac
workup.
Troponin elevation occurred in 33 patients, and 19met
the consensus criteria for MI.28 Troponin was elevated in
the remaining 14 patients without clinical findings (symp-
toms, electrocardiographic, or echocardiographic). The in-
cidence of AF, VA, and 30-day cardiac-related death rate
was 9% (24 of 266), 3% (9 of 266), and 2% (5 of 266),
respectively, and the overall 30-day mortality rate from any
cause was 6% (17 of 266).
Univariable analysis showed no echocardiographic pa-
rameter was associated with AF (Table II, online only) or
Fig 1. Flow diagram shows inclusion and exclusion of patients in
the study.30-day cardiac-related death. The presence of MAC
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no MI: 40 of 153 [26%]; OR, 3.5; 95% CI, 0.9-13.8; P 
.07; Table III, online only). Univariable analysis showed
LACA, EF, LVM, and LVMI were associated with the
presence of VA (Table IV, online only). In multivariable
analysis, however, only LACA was independently associ-
ated with VA (OR, 1.2; 95% CI, 1.0-1.5; P  .07). Nega-
tive stress test results were noted in 152 of the 179 patients
(85%), of whom 9 (6%) sustained an MI during the 30-day
perioperative course. Of the 27 patients who had a positive
stress test result, MI developed in 2 (7%), despite prophy-
lactic revascularization through PCI in selected patients
(Fig 3).
Of the 19 patients withMI, the preoperative stress tests
were interpreted as a negative result in 9, 2 patients primar-
ily underwent cardiac catheterization and received only
Table I. Baseline patient characteristics
Variable Value (N  266)
Age, mean (SD) 74.1 (8.3)
Male, No. (%) 220 (82)
BMI, mean (SD), kg/m2 27.6 (5.8)
History of No. (%)
Coronary artery diseasea 208 (78)
Diabetes mellitus 50 (19)
Chronic heart failure 53 (20)
Hypertension 222 (83)
Stable angina 10 (4)
AVR/MVR 21 (8)
Myocardial infarction 98 (37)
Arrhythmia 62 (23)
CABG 61 (23)
PCI/stent 38 (14)
COPD 92 (35)
Use of home oxygen 42 (16)
Chronic renal insufficiency, No. (%)b 55 (21)
Dialysis, No. (%) 6 (2)
Smoking, No. (%)
Never 30 (11)
Past 194 (73)
Present 42 (16)
ASA risk score, No. (%)
II 3 (1)
III 156 (59)
IV 10 (40)
Type of aneurysm, No. (%)
Juxtarenal 160 (60)
Suprarenal 23 (9)
Thoracoabdominal, No. (%) 82 (31)
I 4 (2)
II 14 (5)
III 19 (7)
IV 44 (17)
Unknown 1 (0.4)
Pseudoaneurysm 1 (0.4)
ASA, American Society of Anesthesiology; AVR, aortic valve replacement;
CABG, coronary artery bypass grafting; COPD, chronic obstructive pulmo-
nary disease; MVR, mitral valve replacement; PCI, percutaneous coronary
intervention.
aHistory of previous myocardial infarction, PCI, CABG, and/or presence of
ischemic changes in electrocardiogram.
bSerum creatinine level 1.5 mg/dL.continued medical treatment because they were unfit forrevascularization, 2 patients had positive stress test results
and underwent PCI but myocardial ischemia still devel-
oped, 3 patients had been cleared by a cardiologist and were
considered to be at high risk for acute coronary syndrome
but had no other options. We were not able to retrieve the
preoperative cardiac evaluation for three patients.
DISCUSSION
In this study, we retrospectively analyzed 395 high-risk
patients with a significantly high prevalence of reported
preoperative CAD (78%) who underwent endovascular re-
pair of a complex aortic aneurysm. Atherosclerotic aneu-
rysm degeneration of the aorta is strongly associated with
other manifestations of atherosclerosis,23 leading to high
suspicion of coronary risk after many types of interventions.
Yet, clinical diagnosis of perioperative MI may be difficult
in patients undergoing major vascular surgery, mainly be-
cause of the transient and silent nature of perioperative MI,
often resulting in non–Q-wave infarction.31
Routine measurement of serum troponin T levels, tele-
metric monitoring, and easy access to bedside echocardio-
gram have improved the ability to accurately diagnose MI,
particularly during the early postoperative period, leading
to a refinement of the criteria for the diagnosis of MI in
2007.28,32 Previous reports of large series of TAAs treated
with conventional open surgery included patients with
variable criteria that are less sensitive than troponin for
detecting MI. Nevertheless, our results showed a compara-
ble 30-day mortality rate and incidence of cardiac events
when confronted with a healthier cohort undergoing con-
ventional open repair (Table V).
In an effort to decrease the risk of MI, the American
College of Cardiology/American Heart Association 2007
guidelines on Perioperative Cardiovascular Evaluation and
Care for Noncardiac Surgery27 recommended that patients
with three or more clinical risk factors (ischemic heart
disease, compensated or prior heart failure, diabetes melli-
tus, renal insufficiency, and cerebrovascular disease) and
poor functional capacity who require vascular surgery
should undergo a cardiac stress test only if it might change
perioperative management. Functional cardiac evaluation
has been the mainstay of preoperative clinical testing using
dobutamine echocardiography or nuclear myocardial per-
fusion imaging. Proper interpretation requires adequate
visualization of the cardiac musculature, either through an
echo window or nuclear imaging, and the ability to expose
the heart to a stressed state (tachycardia). Conventional
management follows further delineation of anatomic de-
fects and the potential to address them in the setting of a
marked functional defect to minimize prior cardiac risk.
The accuracy of this thought process was challenged by
the results of the Coronary Artery Revascularization Pro-
phylaxis (CARP) trial.18,24,33-35 This study provides useful
information but was also heavily criticized given the inclu-
sion of a wide variety of vascular procedures included in the
stratification. Such data resulted in the conclusion that a
conservative strategy is warranted in most patients with
stable symptoms.27 Whether and how a patient requiring
rgery
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risk standpoint remains a focus of debate.
The 2-dimensional transthoracic echocardiogram is
well accepted for evaluation of cardiac function and for
providing powerful prognostic information for cardiovas-
cular outcomes, such as presence of left ventricular hyper-
trophy,36 aortic sclerosis,37 and left ventricle ejection frac-
tion,15,37 all of which have been associated with a varying
degree of cardiac risk. The association of echocardiographic
parameters with underlying CAD is less well established,
however. Chang et al38 noted that LV enlargement, LV
hypertrophy, LVEF, wall motion abnormality, mitral annu-
lar calcification, and aortic sclerosis were predictors of
perfusion defects by single photon-emission computed to-
mography and that EF 50%, WMA, MAC, and aortic
sclerosis were predictors of coronary artery stenosis by
angiography. None of these factors have been shown to be
useful in assessing risk before aneurysm surgery.
Our results confirm the lack of predictive utility for
stress test in the identification of patients at risk for MI. MI
was a complication in 6% of patients with a negative stress
test result and in 7% with a positive stress test result. Only
30% of patients with positive stress test result underwent
PCI. The routine use of statins and -blockers (unless
contraindicated) may explain the relatively overall low risk.
Of all the preoperative parameters assessed, only MAC was
Fig 2. Path of patients’ cardiac assessment before en
Coronary artery bypass grafting; PCI, percutaneous co
patients were not available; 3 developed myocardial infar
MI after surgery; #2 patients in this group developed M
surgery; 3 patients in this group developed MI after suweakly associated with MI.Presence of aortic valvular calcification, aortic stenosis,
andMAC have been shown to bemanifestations of subclin-
ical cardiovascular disease and associated with an increased
risk of CAD and cardiac death.39-41 Adler et al,42 compar-
ing the results of coronary catheterization in age-matched
patients with and withoutMAC, found that the presence of
annular calcification was an independent predictor for cor-
onary artery stenosis. In agreement with that, we found that
the presence of MAC showed a trend to significance in
predicting development of MI during the perioperative
period. This association may be due to shared risk factors,
including age, hypertension, hyperlipidemia, diabetes, and
obesity. Carpentier et al43 proposed a mechanism of MAC
where mechanical factors (blood pressure and excess ten-
sion on leaflets) together with chemical factors (collagen
and proteoglycans alteration) would cause annulus dehis-
cence and subsequent calcification. These data reinforce the
theory that MAC may more accurately predict the effect of
longitudinal blood pressure elevation than the blood pres-
sure reading at one examination,41 thus a marker of arterial
stiffness.
Although readily treatable, atrial and ventricular dys-
rhythmias can both be fatal. Patients at risk for the devel-
opment of such events should, at minimum, be closely
monitored. The use of prophylactic medications, such as
amiodarone, before the development of AF is a consider-
scular repair of thoracoabdominal aneurysm. CABG,
y intervention. *Preoperative evaluation data from 20
(MI) after surgery;9 patients in this group developed
r surgery; 2 patients in this group developed MI after
.dova
ronar
ction
I afteation, but again remains the subject of discussion. Our
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high LVM and LVMI are associated with VA, but no echo
parameters were found to be associated with AF.
This analysis has several weaknesses. Given the highly
selected value of the population, the results may have limited
Fig 3. Clinical course of patients undergoing stress test
Percutaneous coronary intervention.
Table V. Mortality and cardiac-related mortality at 30 day
thoracoabdominal surgical and combined endovascular and
Repair/first author No.
30-day
N
Open TAA repair
Coselli,2 2007 2286 150
Schepens,44 2009 571 51
Conrad,11 2007 455 39
CESA
Quinones-Baldrich,45 2009 20
Black,46 2006 17 3
Resch,47 2006 13
Our study 266 17
N/A, Not applicable; TAA, thoracoabdominal aneurysm.generalizability. The retrospective nature of the study affectedthe quality of the data and forced us to excludemany patients.
Limited patient numbers, particularly those with a positive
stress test result or treatedwith coronary interventions, thwart
strong established conclusions.
Finally, the somewhat subjective values of both stress
e endovascular thoracoabdominal aneurysm repair. PCI,
d incidence of cardiac events in patients undergoing
gical approach (CESA) repair
ality Cardiac-related death Cardiac events
No. (%) No. (%)
6) N/A 181 (7.9)
) 14 (2.5%) N/A
) 5 (1%) 67 (14.7)
0 1
1 N/A
0 N/A
) 5 (2) 45/266 (17)befors an
sur
mort
o. (%)
(6.5
(8.9
(8.6
0
(18)
3
(6.3and echo interpretation coupled with a composite end
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simple or binary patient management strategies.
CONCLUSIONS
Given these data, it remains difficult to find a benefit in
the routine performance of stress tests before complex
endovascular aneurysm repair in a patient without cardiac
symptoms. Echo evaluation may help to stratify patients
into those in whom postoperative dysrhythmias are more
likely to develop and thus warrant closer monitoring. Yet,
we cannot ignore the significant incidence of MI and thus
recommend that all postoperative patients should undergo
troponin monitoring with other appropriate diagnostic
tests to allow for optimal management of any ischemia.
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Variable
Atri
Yes
Wall motion abnormality, No. (%) 2/20 (10)
Mitral anular calcification, No. (%) 7/20 (35)
Left atrial cavity, mean (SD) cm2 21.8 (5.1)
No. 12
Left atrial size, mean (SD) cm 4.2 (0.7)
No. 18
Ejection fraction, mean (SD) 0.52 (0.09)
No. 21
LV mass, mean (SD), g 219.7 (67.3)
No. 20
LV mass index, mean (SD), g/m2 112.7 (25.1)
No. 19
Stage diastolic dysfunction, No. (%)
1 11/13 (85)
2 2/13 (15)
3 0
CI, Confidence interval; LV, left ventricle; OR, odds ratio; SD, standard detion between echo parameters and atrial fibrillation
al fibrillation
OR (95% CI)
(Univariate) PNo
35/144 (88) 0.3 (0.1-1.6) .3
38/142 (27) 1.5 (0.6-3.9) .5
22.3 (7.2) 1.0 (0.9-1.1) .8
102
4.6 (3.1) 0.8 (0.5-1.5) .5
124
0.50 (0.13) 3.8 (0.1-162.3) .5
192
240.1 (90.8) 1.0 (1.0-1.0) .4
136
119.5 (43.6) 1.0 (1.0-1.0) .5
125
87/101 (86) 1 .8
10/101 (10) 1.5 (0.3-8.2)
4/101 (4) Extreme
JOURNAL OF VASCULAR SURGERY
Volume 53, Number 1 Bub et al 27.e2Table III (online only). Univariate analysis of the association between echo parameters and myocardial infarction
Variable
Miocardial infarction
OR (95% CI)
(Univariate) PYes No
Wall motion abnormality, No. (%) 1/9 (11) 36/155 (23) 0.4 (0.1-3.4) .4
Mitral anular calcification, No. (%) 5/9 (56) 40/153 (26) 3.5 (0.9-13.8) .07
Left atrial cavity, mean (SD), cm2 22.2 (2.7) 22.3 (7.2) 1.0 (0.9-1.1) .9
No. 5 109
Left atrial size, mean (SD), cm 4.7 (1.0) 4.6 (3.0) 1.0 (0.8-1.2) .9
No. 9 133
Ejection fraction, mean (SD) 0.47 (0.17) 0.51 (0.13) 0.1 (0.01-7.2) .3
No. 12 201
LV mass, mean (SD), g 228.3 (71.6) 238.1 (89.4) 1.0 (1.0-1.0) .7
No. 10 146
LV mass index, mean (SD), g/m2 108.8 (25.7) 119.1 (42.3) 1.0 (1.0-1.0) .5
No. 7 137
Stage diastolic dysfunction, No. (%)
1 3/5 (60) 95/109 (87) 1 .3
2 1/5 (20) 11/109 (10) 2.9 (0.3-30.1)
3 1/5 (20) 3/109 (3) 10.6 (0.7-133.7)CI, Confidence interval; LV, left ventricle; OR, odds ratio; SD, standard deviation.Table IV (online only). Univariable analysis of the association between echo parameters and ventricular arrhythmia
Variable
Ventricular arrhythmia
OR (95% CI)
(Univariate) PYes No
Wall motion abnormality, No. (%) 1/4 (25) 36/160 (22) 1.1 (0.1-11.4) .9
Mitral anular calcification, No. (%) 1/4 (25) 44/158 (28) 0.9 (0.1-8.5) .9
Left atrial cavity, mean (SD), cm2 39.0 (7.1) 22.0 (6.7) 1.2 (1.0-1.4) .01
No. 2 112
Left atrial size, mean (SD), cm 4.8 (0.8) 4.6 (2.9) 1.0 (0.8-1.4) .9
No. 3 139
Ejection fraction, mean (SD) 0.33 (0.15) 0.51 (0.13) Extreme .002
No. 7 206
LV mass, mean (SD), g 347.6 (63.4) 234.6 (87.1) 1.0 (1.0-1.0) .02
No. 4 152
LV mass index, mean (SD), g/m2 189.3 (64.0) 117.1 (40.1) 1.0 (1.0-1.0) .01
No. 3 141
Stage diastolic dysfunction, No. (%)
1 0 85/97 (88) 1 .9
2 0 9/97 (9) Extreme
3 1/1 (100) 3/97 (3) ExtremeCI, Confidence interval; LV, left ventricle; OR, odds ratio; SD, standard deviation.
